Form 483

Kofinas Fertility Group Form 483, 2025-04-09

FDA issued a Form 483 to Kofinas Fertility Group on 2025-04-09 with 4 public-safe observations.

483· Form 483 issuedBiologics4 observations

Kofinas Fertility Group · New York, United States · Issued April 9, 2025

Overview

  • 4 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Apr 2025
21 CFR 1271.50(a)

Determination based on screening and testing

Cited by Irina Gaberman

9 Apr 2025
21 CFR 1271.50(a)

Responsible person to determine, document

Cited by Irina Gaberman

9 Apr 2025
21 CFR 1271.55(d)(2)

Accurate, indelible, legible

Cited by Irina Gaberman

9 Apr 2025
21 CFR 1271.90(c)

Eligibility not required--warning labels

Cited by Irina Gaberman

Inspected site

KFKofinas Fertility GroupNew York, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.50(a)Cited across public-safe Form 483 observations2x
21 CFR 1271.55(d)(2)Cited across public-safe Form 483 observations1x
21 CFR 1271.90(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere